Bridging Biotech Between China and the West

We enable cross-border biotech partnerships, helping Chinese innovators reach global markets and Western innovators succeed in China.

The Innovator’s Dilemma

China is one of the fastest-growing biotech markets, offering breakthrough innovation at scale. Yet complex regulations, uncertain pathways, and global headwinds often slow or stall deals. Making successful cross-border biotech transactions challenging. Success requires more than a partner. It requires on-the-ground expertise.

For Western biotechs, this means trusted local insight; for Chinese innovators, it means navigating FDA/EMA standards and connecting with the right global partners. At SEQOVA, we bridge both worlds, turning barriers into opportunities for growth.

The SEQOVA DNA

Clarity

Cutting through complexity to identify assets with true strategic value

Courage

Guiding innovators through high-stakes, cross-border decisions with confidence

Commitment

Partnering from insight to market, ensuring every opportunity reaches its potential

Tailored solutions for two worlds of innovators.

For Chinese Innovators:
Going Global

Navigate Global Regulatory Pathways: Position assets for FDA and EMA compliance with confidence, from Proof of Concept (PoC) to New Drug Application (NDA).
全球监管合规及路径支持: 从概念验证（PoC）到新药申请（NDA），为新药项目规划 FDA 和 EMA 合规方案，确保全球市场准入。

Structure Deals & Partnerships: Out-license, co-develop, or engage in M&A to maximize value and accelerate growth.
许可与投资支持: 设计外部许可、联合开发及并购交易，最大化资产价值并加速发展。

Connect with Strategic Partners: Access trusted Western pharma and biotech networks to expand global reach.
战略合作伙伴: 连接可信赖的西方制药大厂和创新生物医药技术公司网络，扩张全球影响力。

For Western Innovators: Succeeding in China

Strategic Asset Sourcing: Identify the right Chinese innovations that complement your pipeline, increase valuation, and strengthen your platform.

Licensing & Acquisition Support: Align with the best partners to create high-value, low-risk deals that accelerate market entry.

Partnership Enablement: Bring together trusted Chinese innovators and expert teams to ensure long-term growth, credibility, and operational success.

The SEQOVA Advantage

At SEQOVA, we combine access, insight, and execution to unlock opportunities that others overlook.

On-the-Ground-Access

Our China team provides real-time insights, regulatory expertise, and cultural understanding. Built on trusted relationships that quietly open doors.

Beyond the Obvious

We specialize in uncovering Tier-2 and Tier-3 innovators. The hidden gems driving the next wave of high-value biotech assets.

Grounded in Technical Excellence

With a foundation in regulatory strategy and quality assurance, and supported by our expert network, we deliver on-demand technical depth. Every opportunity is assessed with scientific rigor and a clear path to success.

Investing in the Future

SEQOVA doesn’t just advise.
We lead and structure transformative opportunities, aligning the right assets with the right partners to create value.

Strategic Investments

We identify high-potential assets and assemble the right team of experts and partners to accelerate their development and market readiness.

Next-Generation Projects